Gallize Pharmaceuticals Llp

Gallize Pharmaceuticals Llp - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
LLPIN AAF-4255 Incorporated 04 January 2016 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
₹2.95 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Last financials
Mar 2025
Balance sheet date

About Gallize Pharmaceuticals Llp

Data last updated: 13 February 2026

Gallize Pharmaceuticals Llp is a limited liability partnership company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 04 January 2016, the LLP has been in operation for over 10 years.

Registered with ROC Ahmedabad under LLPIN AAF-4255.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Shrujalbahen Kaumilbhai Modi and Sonalben Navin Modi.

Accounts filed on 31 March 2025. Office: Gf – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061.

As per MCA filings, the LLP has open charges of ₹2.95 Cr on record.

Company Details of Gallize Pharmaceuticals Llp
LLPIN AAF-4255
Incorporation Date 04 January 2016
Total Obligation of Contribution ₹1 Lakh
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Shrujalbahen Kaumilbhai Modi Designated Partner Sonalben Navin Modi Partner Kaumil Navnitbhai Modi Designated Partner
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Gf – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061
  • Industry
    Pharma, Drug Formulation & Development
Company report
Gallize Pharmaceuticals Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Gallize Pharmaceuticals Llp report

Financials, compliance, directors, charges, ownership and filings for Gallize Pharmaceuticals Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Gallize Pharmaceuticals Llp

Gallize Pharmaceuticals Llp is currently managed by 4 designated partners, with 2 former designated partners having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Shrujalbahen Kaumilbhai Modi
Also directs: Tripada Lifecare Private Limited
Designated Partner 04 Jan 2016 10 Years 6 Months Current
Sonalben Navin Modi Partner 04 Jan 2016 10 Years 6 Months Current
Kaumil Navnitbhai Modi
Also directs: Thc Pharma Wellness Private Limited, Smonkare Impex Private Limited, Tripada Healthcare Private Limited and 2 more
Designated Partner 04 Jan 2016 10 Years 6 Months Current
Navin Dahyalal Modi Partner 04 Jan 2016 10 Years 6 Months Current
View all designated partners

Financials of Gallize Pharmaceuticals Llp FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Gallize Pharmaceuticals Llp

Open charges
₹2.95 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Icici Bank Limited₹2.95 Cr
Latest charge details
DateLenderAmountStatus
03 Jul 2021 Icici Bank Limited ₹1.8 Cr Open
07 Jul 2016 Icici Bank Limited ₹1.15 Cr Open

Total charge records: 2 View all charges

Employees and EPFO Compliance at Gallize Pharmaceuticals Llp

View historical data on people associated with Gallize Pharmaceuticals Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Gallize Pharmaceuticals Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Gallize Pharmaceuticals Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Gallize Pharmaceuticals Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Gallize Pharmaceuticals Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Gallize Pharmaceuticals Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Gallize Pharmaceuticals Llp

MSME Payment Delays by Gallize Pharmaceuticals Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Gallize Pharmaceuticals Llp

Subsidiaries & Group Companies of Gallize Pharmaceuticals Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Gallize Pharmaceuticals Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Gallize Pharmaceuticals Llp

MCA Filings & Documents of Gallize Pharmaceuticals Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Gallize Pharmaceuticals Llp

Activity
31 Mar 2025
Gallize Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Gallize Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
03 Jul 2021
A charge with Icici Bank Limited amounted to Rs. 180.00 Lakh with Charge ID 100456982 was registered on 03 Jul 2021.
Charges
07 Jul 2016
A charge with Icici Bank Limited amounted to Rs. 115.00 Lakh with Charge ID 100035783 was registered on 07 Jul 2016.
Directors
04 Jan 2016
Shrujalbahen Kaumilbhai Modi was appointed as a Designated Partner on 04 Jan 2016 & has been associated with this company since 10 years 6 months.
Directors
04 Jan 2016
Sonalben Navin Modi was appointed as a Partner on 04 Jan 2016 & has been associated with this company since 10 years 6 months.

Frequently Asked Questions about Gallize Pharmaceuticals Llp

Gallize Pharmaceuticals Llp is an active limited liability partnership in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 04 January 2016 (10+ years old) and is registered under LLPIN AAF-4255.

The current designated partners of Gallize Pharmaceuticals Llp are:

The primary industry of Gallize Pharmaceuticals Llp is pharma. The LLP specifically operates in drug formulation and development. The LLP is currently active in this sector.

Gallize Pharmaceuticals Llp can be reached at the registered office: Gf – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061.

The total obligation of contribution is ₹1 Lakh.

The LLP has its registered office at Gf – 10 Malhar Complex Mukti Park Soc. Vibhag – 4 Nr. Sola Over Bridge Ghatlodiya, Ahmedabad, Gujarat, India – 380061.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available